Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/24/2025

Adverse Effects of Paroxetine

Introduction to Paroxetine-Associated Adverse Effects

  • The American Academy of Child and Adolescent Psychiatry recommends starting with subtherapeutic "test" doses to assess tolerability, as initial adverse effects can include various systemic symptoms 1
  • Paroxetine has the highest risk of discontinuation syndrome among all SSRIs, so if leg cramps or other intolerable side effects necessitate stopping the medication, taper over a minimum of 10-14 days to limit withdrawal symptoms 1

Evidence for Adverse Effects

  • Muscle and leg cramps were statistically more frequent in patients taking donepezil, with a relative risk of 9.62 (95% CI, 3.48 to 26.58) in patients with vascular dementia, suggesting serotonergic and cholinergic medications can cause this adverse effect 2
  • Paroxetine is listed among antidepressant medications that can cause photosensitivity and other systemic effects, suggesting it has broader systemic effects beyond its primary serotonergic action 3

Common Side Effects

  • Approximately 63% of patients receiving SSRIs like paroxetine experience at least one adverse effect during treatment 4
  • The most frequently reported adverse effects with paroxetine include gastrointestinal effects, such as nausea, diarrhea, dry mouth, and constipation 4

Clinical Considerations

  • If leg cramps develop while taking paroxetine, consider the timing of onset, as most SSRI side effects emerge early in treatment 1
  • Close monitoring is particularly important within the first 1-2 weeks of initiation and after dosage adjustments 1
  • Severe or persistent cramps may warrant evaluation for electrolyte disturbances or consideration of alternative antidepressant therapy 3

Discontinuation Syndrome Associated with Paroxetine

Introduction to Discontinuation Syndrome

  • The American Academy of Child and Adolescent Psychiatry identifies paroxetine as being specifically associated with discontinuation syndrome, which includes symptoms such as brain zaps, alongside fluvoxamine and sertraline 5

Clinical Presentation and Management

  • In pediatric patients, the American Academy of Pediatrics documented similar discontinuation symptoms including irritability, tremors, and sleep disturbance when SSRIs like paroxetine are stopped 6
  • These sensory disturbances are distinct from serotonin syndrome, which presents with the triad of mental status changes, autonomic hyperactivity, and neuromuscular abnormalities 5